Effects of carbenoxolone on gastric release of prostaglandin (PG)E2 in patients with peptic ulcer disease.
D000328:Adult; D002229:Carbenoxolone / Q000494:pharmacology*; D015232:Dinoprostone; D005260:Female; D005502:Food; D005750:Gastric Juice / Q000378:metabolism; D005753:Gastric Mucosa / Q000378:metabolism*; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010418:Pentagastrin; D010437:Peptic Ulcer / Q000378:metabolism*; D011458:Prostaglandins E / Q000096:biosynthesis*
D011458:Prostaglandins E; D010418:Pentagastrin; D015232:Dinoprostone; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid